Cite
HARVARD Citation
Loef, M. et al. (n.d.). Tumor necrosis factor-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up. Osteoarthritis and cartilage. pp. S300-S301. [Online].